Skip to main content
ARWR logo
ARWR
(NASDAQ)
Arrowhead Pharmaceuticals, Inc.
$77.14-- (--)
Loading... - Market loading

Arrowhead Pharmaceuticals (ARWR) Stock Price & Financial Analysis

Arrowhead Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$73.75 - $77.49
52-Week High$80.27
52-Week Low$14.30
Open$74.28
Volume1.54M
Average Volume (3M)1.85M
Market Cap10.30B
Shares Outstanding140.71M
P/E Ratio (TTM)50.91
Price to Sales (P/S)9.44
Price to Book (P/B)18.11
EV/EBITDA30.14
Revenue (TTM)1.09B
Net Income (TTM)202.26M
Free Cash Flow (TTM)322.01M
EPS (TTM)$1.47
Profit Margin18.54%
Operating Margin27.55%
Return on Equity (ROE)35.58%
Debt to Equity0.36
50-Day MA$65.64
200-Day MA$50.70
52-Week Change456.48%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Arrowhead Pharmaceuticals

What is the current stock price for ARWR?

As of the latest trading session, ARWR stock trades at $77.14. The 52-week range is $14.30–$80.27, with a day range of $73.75–$77.49.

What is the P/E ratio for ARWR?

Arrowhead Pharmaceuticals's trailing P/E ratio is 50.9, meaning investors pay $50.9 for every $1 of annual earnings.

Does ARWR pay dividends?

Arrowhead Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARWR?

Based on 2 analysts, the consensus for ARWR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ARWR?

Arrowhead Pharmaceuticals's market capitalization is $10.85B, classifying it as a large-cap company..